Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Thomas Powles, Alain Ravaud, Sanjeev Mariathasan et al.|The Lancet|2017

Cited by 1.4k